<?xml version="1.0" encoding="UTF-8"?>
<OAI-PMH xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2022-03-11T00:58:33Z</responseDate>
  <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:7912426" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:pubmedcentral.nih.gov:7912426</identifier>
        <datestamp>2021-02-28</datestamp>
        <setSpec>antibiot</setSpec>
        <setSpec>pmc-open</setSpec>
      </header>
      <metadata>
        <article xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.3/ https://jats.nlm.nih.gov/archiving/1.3/xsd/JATS-archivearticle1-3.xsd" article-type="research-article">
          <front>
            <journal-meta>
              <journal-id journal-id-type="nlm-ta">Antibiotics (Basel)</journal-id>
              <journal-id journal-id-type="iso-abbrev">Antibiotics (Basel)</journal-id>
              <journal-id journal-id-type="publisher-id">antibiotics</journal-id>
              <journal-title-group>
                <journal-title>Antibiotics</journal-title>
              </journal-title-group>
              <issn pub-type="epub">2079-6382</issn>
              <publisher>
                <publisher-name>MDPI</publisher-name>
              </publisher>
            </journal-meta>
            <article-meta>
              <article-id pub-id-type="accession">PMC7912426</article-id>
              <article-id pub-id-type="pmcid">PMC7912426</article-id>
              <article-id pub-id-type="pmc-uid">7912426</article-id>
              <article-id pub-id-type="pmid">33525354</article-id>
              <article-id pub-id-type="pmid">33525354</article-id>
              <article-id pub-id-type="doi">10.3390/antibiotics10020121</article-id>
              <article-id pub-id-type="publisher-id">antibiotics-10-00121</article-id>
              <article-categories>
                <subj-group subj-group-type="heading">
                  <subject>Article</subject>
                </subj-group>
              </article-categories>
              <title-group>
                <article-title>Impact of <italic>Salmonella</italic> Control Programmes in Poultry on Human <italic>Salmonellosis</italic> Burden in Greece</article-title>
              </title-group>
              <contrib-group>
                <contrib contrib-type="author">
                  <name>
                    <surname>Tzani</surname>
                    <given-names>Myrsini</given-names>
                  </name>
                  <xref ref-type="aff" rid="af1-antibiotics-10-00121">1</xref>
                  <xref ref-type="aff" rid="af2-antibiotics-10-00121">2</xref>
                  <xref rid="c1-antibiotics-10-00121" ref-type="corresp">*</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Mandilara</surname>
                    <given-names>Georgia</given-names>
                  </name>
                  <xref ref-type="aff" rid="af3-antibiotics-10-00121">3</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Dias</surname>
                    <given-names>Joana Gomes</given-names>
                  </name>
                  <xref ref-type="aff" rid="af4-antibiotics-10-00121">4</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Sideroglou</surname>
                    <given-names>Theologia</given-names>
                  </name>
                  <xref ref-type="aff" rid="af2-antibiotics-10-00121">2</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Chrysostomou</surname>
                    <given-names>Anthi</given-names>
                  </name>
                  <xref ref-type="aff" rid="af2-antibiotics-10-00121">2</xref>
                </contrib>
                <contrib contrib-type="author">
                  <contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-0065-5766</contrib-id>
                  <name>
                    <surname>Mellou</surname>
                    <given-names>Kassiani</given-names>
                  </name>
                  <xref ref-type="aff" rid="af2-antibiotics-10-00121">2</xref>
                  <xref rid="c1-antibiotics-10-00121" ref-type="corresp">*</xref>
                </contrib>
              </contrib-group>
              <contrib-group>
                <contrib contrib-type="editor">
                  <name>
                    <surname>Frye</surname>
                    <given-names>Jonathan</given-names>
                  </name>
                  <role>Academic Editor</role>
                </contrib>
              </contrib-group>
              <aff id="af1-antibiotics-10-00121"><label>1</label>European Programme for Intervention Epidemiology Training (EPIET), European Centre for Disease Prevention and Control (ECDC), 169 73 Stockholm, Sweden</aff>
              <aff id="af2-antibiotics-10-00121"><label>2</label>Department of Foodborne and Waterborne Diseases, Hellenic National Public Health Organisation (EODY), 3-5 Agrafon Str., 15123 Marousi-Attiki, Greece; <email>t.sideroglou@eody.gov.gr</email> (T.S.); <email>a.chrysostomou@eody.gov.gr</email> (A.C.)</aff>
              <aff id="af3-antibiotics-10-00121"><label>3</label>National Reference Centre for Salmonella, Department of Public Health Policy, School of Public Health, University of West Attica, 196 Alexandras Ave., 11521 Athens, Greece; <email>gmandilara@uniwa.gr</email></aff>
              <aff id="af4-antibiotics-10-00121"><label>4</label>European Centre for Disease Prevention and Control (ECDC), Gustav III:s Boulevard 40, 169 73 Solna, Sweden; <email>joana.gomes.dias@ecdc.europa.eu</email></aff>
              <author-notes>
                <corresp id="c1-antibiotics-10-00121"><label>*</label>Correspondence: <email>pavloszalimidis@yahoo.com</email> (M.T.); <email>k.mellou@eody.gov.gr</email> (K.M.); Tel.: +30-6932645642 (M.T.); +30-6974438453 (K.M.)</corresp>
              </author-notes>
              <pub-date pub-type="epub">
                <day>28</day>
                <month>1</month>
                <year>2021</year>
              </pub-date>
              <pub-date pub-type="collection">
                <month>2</month>
                <year>2021</year>
              </pub-date>
              <volume>10</volume>
              <issue>2</issue>
              <elocation-id>121</elocation-id>
              <history>
                <date date-type="received">
                  <day>25</day>
                  <month>12</month>
                  <year>2020</year>
                </date>
                <date date-type="accepted">
                  <day>26</day>
                  <month>1</month>
                  <year>2021</year>
                </date>
              </history>
              <permissions>
                <copyright-statement>© 2021 by the authors.</copyright-statement>
                <copyright-year>2021</copyright-year>
                <license license-type="open-access">
                  <license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p>
                </license>
              </permissions>
              <abstract>
                <p>Since 2008, veterinary authorities in Greece have implemented national control programmes (NSCPs) targeting <italic>S. Enteritidis</italic> (SE) and <italic>S. Typhimurium</italic> (ST) in poultry. We assessed the effect of the programs on the reported number of human isolates. Using monthly data for 2006–2017, we defined two groups (SE, ST) and one control group with serotypes unrelated to poultry or eggs. For SE we also analysed data for 2006–2015 due to a multi-county SE outbreak in 2016. We performed an interrupted time series analysis and used a negative binominal regression model. For both SE and ST, there was no significant trend of the isolation rate before or after NSCPs’ introduction. After the NSCPs’ introduction there was an increasing rate (IRR: 1.005, 95% CI: 1.001–1.008) for control serotypes and a decreasing one for SE (IRR: 0.990, 95% CI: 0.986–0.995) (for 2009 to 2015 analysis). From 2006 to 2017, NSCPs had a statistically significant impact on the number of SE isolates that decreased by 49% (IRR:0.511, 95% CI: 0.353–0.739). No impact was shown on the number of ST (<italic>p</italic>-value = 0.741) and control isolates (<italic>p</italic> = 0.069). As a conclusion, NSCP’s implementation was associated with decreased SE isolates and overall burden of salmonellosis; however further measures aiming at human salmonellosis due to ST, should be considered.</p>
              </abstract>
              <kwd-group>
                <kwd>
                  <italic>salmonellosis</italic>
                </kwd>
                <kwd>National Salmonella Control Programmes</kwd>
                <kwd>interrupted time series analysis</kwd>
                <kwd>public health</kwd>
              </kwd-group>
            </article-meta>
          </front>
          <body>
            <sec sec-type="intro" id="sec1-antibiotics-10-00121">
              <title>1. Introduction</title>
              <p>Non-typhoidal salmonellosis is caused by bacteria of genus <italic>Salmonella</italic> spp. which is one of the most frequently isolated foodborne pathogens, accounting for 93.8 million foodborne illnesses and 155,000 deaths per year [<xref rid="B1-antibiotics-10-00121" ref-type="bibr">1</xref>]. To date, over 2600 <italic>Salmonella</italic> serotypes have been identified and more than half of them belong to <italic>Salmonella enterica</italic> subsp. <italic>enterica</italic> [<xref rid="B2-antibiotics-10-00121" ref-type="bibr">2</xref>].</p>
              <p>In the EU, over 90,000 salmonellosis cases are recorded every year making salmonellosis the second most frequently reported zoonotic disease after <italic>Campylobacter</italic> spp. infection [<xref rid="B3-antibiotics-10-00121" ref-type="bibr">3</xref>]. It has been estimated that the overall annual economic burden of human salmonellosis in Europe is as high as three billion euros [<xref rid="B3-antibiotics-10-00121" ref-type="bibr">3</xref>]. The three most commonly reported <italic>Salmonella</italic> serotypes, belonging to <italic>Salmonella enterica</italic> subsp. <italic>enterica,</italic> are Enteritidis, Typhimurium and the monophasic variant of Typhimurium with the antigenic formula 1,4,[5],12:i:- (referred as <italic>S. Enteritidis</italic>, <italic>S. Typhimurium</italic> and monophasic <italic>S. Typhimurium</italic> hereafter). The risk of infection is mostly associated with the consumption of contaminated eggs, pig and poultry meat [<xref rid="B3-antibiotics-10-00121" ref-type="bibr">3</xref>].</p>
              <p>To protect consumers from <italic>Salmonella</italic> spp., the EU has adopted an integrated approach to food safety from “farm to fork” that includes the annual monitoring of salmonellosis notification rate in humans, the control of the pathogen in specific animal species and the production of food free of <italic>Salmonella</italic> [<xref rid="B4-antibiotics-10-00121" ref-type="bibr">4</xref>,<xref rid="B5-antibiotics-10-00121" ref-type="bibr">5</xref>,<xref rid="B6-antibiotics-10-00121" ref-type="bibr">6</xref>,<xref rid="B7-antibiotics-10-00121" ref-type="bibr">7</xref>,<xref rid="B8-antibiotics-10-00121" ref-type="bibr">8</xref>,<xref rid="B9-antibiotics-10-00121" ref-type="bibr">9</xref>,<xref rid="B10-antibiotics-10-00121" ref-type="bibr">10</xref>,<xref rid="B11-antibiotics-10-00121" ref-type="bibr">11</xref>]. The control of the pathogen mainly focuses at poultry meat and eggs. Regulation (EC) No 2160/2003 sets targets for the reduction of targeted salmonella serotypes in flocks of breeding hens, laying hens, broilers, breeding turkeys and fattening turkeys [<xref rid="B6-antibiotics-10-00121" ref-type="bibr">6</xref>,<xref rid="B7-antibiotics-10-00121" ref-type="bibr">7</xref>,<xref rid="B8-antibiotics-10-00121" ref-type="bibr">8</xref>,<xref rid="B9-antibiotics-10-00121" ref-type="bibr">9</xref>,<xref rid="B10-antibiotics-10-00121" ref-type="bibr">10</xref>]. The targets are set on two serotypes (<italic>S.</italic> Enteritidis and <italic>S. Typhimurium</italic>, including monophasic <italic>S. Typhimurium</italic>), except for breeding hens for which also <italic>S.</italic> Hadar, <italic>S.</italic> Virchow and <italic>S.</italic> Infantis are also targeted. In order to achieve the targets, Member States have introduced National Salmonella Control Programmes (NSCPs) in poultry populations. NSCPs include enhanced surveillance on the basis of specific sampling protocols according to EU legislation, vaccination against <italic>S.</italic> Enteritidis and <italic>S. Typhimurium</italic> in poultry, implementation of strict biosecurity measures, restriction of movements and destruction or heat treatment of infected birds and eggs, in the event of the detection of targeted <italic>Salmonella</italic> serotypes in a flock of poultry [<xref rid="B7-antibiotics-10-00121" ref-type="bibr">7</xref>,<xref rid="B8-antibiotics-10-00121" ref-type="bibr">8</xref>,<xref rid="B9-antibiotics-10-00121" ref-type="bibr">9</xref>,<xref rid="B10-antibiotics-10-00121" ref-type="bibr">10</xref>,<xref rid="B12-antibiotics-10-00121" ref-type="bibr">12</xref>].</p>
              <p>In Greece, 10,321 salmonellosis cases were reported from 2004 to 2019 with a mean annual notification rate of 5.9 cases per 100,000 population [<xref rid="B13-antibiotics-10-00121" ref-type="bibr">13</xref>]. <italic>S. Enteritidis</italic>, <italic>S. Typhimurium</italic> and monophasic <italic>S. Typhimurium</italic> accounted for 80% of the total isolated serotypes in the country [<xref rid="B13-antibiotics-10-00121" ref-type="bibr">13</xref>]. NSCPs were implemented for the first time in 2007 in breeders [<xref rid="B14-antibiotics-10-00121" ref-type="bibr">14</xref>]. In 2008, their implementation expanded to layers, in 2009 to broilers and since 2010, the programmes have also been covering breeding and fattening turkeys [<xref rid="B14-antibiotics-10-00121" ref-type="bibr">14</xref>].</p>
              <p>The aim of this study was to evaluate the impact of NSCPs in poultry breeding on human salmonellosis reported number of cases.</p>
            </sec>
            <sec sec-type="results" id="sec2-antibiotics-10-00121">
              <title>2. Results</title>
              <sec id="sec2dot1-antibiotics-10-00121">
                <title>2.1. Descriptive Data</title>
                <p>From 2006 to 2017, 5,432 human <italic>Salmonella</italic> spp. isolates were serotyped; 42% (2260) were <italic>S. Enteritidis</italic>, 13% (681) <italic>S. Typhimurium</italic>, 5% (247) monophasic <italic>S. Typhimurium</italic> and 40% (2244) other <italic>Salmonella</italic> serotypes. The mean number of human <italic>Salmonella</italic> spp. isolates per year was 453 (min: 241, max: 630).</p>
                <p><xref ref-type="fig" rid="antibiotics-10-00121-f001">Figure 1</xref> depicts the monthly distribution of <italic>Salmonella</italic> spp., <italic>S. Enteritidis</italic>, <italic>S. Typhimurium</italic>, monophasic <italic>S. Typhimurium</italic> and “Control <italic>Salmonella</italic> serotypes” of human isolates for the period 2006 to 2017 and the annual trend of these serotypes using moving averages. According to the <xref ref-type="fig" rid="antibiotics-10-00121-f001">Figure 1</xref>, there was a decrease in the total number of <italic>Salmonella</italic> cases, <italic>S. Enteritidis</italic> cases, and cases due to “Control <italic>Salmonella</italic> serotypes” after the implementation of NSCPs in 2008. However, the number of <italic>Salmonella</italic> cases due to the above-mentioned serotypes started to increase again in different time periods for different serotypes. <italic>S. Enteritidis</italic> increased sharply in 2016 and decreased again in 2017.</p>
                <p>From 2006 to 2017 the trend of the number of all <italic>Salmonella</italic> serotypes, and of <italic>S. Enteritidis</italic> isolates were statistically significantly decreasing while there was no significant trend for the number of <italic>S. Typhimurium</italic>, monophasic <italic>S. Typhimurium</italic>, and “Control <italic>Salmonella</italic> serotypes” (<xref rid="antibiotics-10-00121-t001" ref-type="table">Table 1</xref>).</p>
              </sec>
              <sec id="sec2dot2-antibiotics-10-00121">
                <title>2.2. Results of the Interrupted Time Series Analysis</title>
                <p>During the study period 2006–2017, there was no evidence of significant trends in the number of <italic>S. Enteritidis</italic> isolates both, before, as well after, the introduction of the NSCPs. However, the programs had a statistically significant impact on the total number of <italic>S. Enteritidis</italic> human isolates and resulted in a statistically significant decrease of their total number by 49% (IRR: 0.511, 95% CI: 0.353–0.739).</p>
                <p>When analysis for 2006–2015 was performed there was no trend of the number of <italic>S.</italic>
<bold>Enteritidis</bold> isolates before the introduction of the intervention, however, afterwards there was a statistically significantly decreasing trend and the reported number of <italic>S. Enteritidis</italic> isolates decreased by 0.95% per month on average (IRR: 0.990, 95% CI: 0.986–0.995). The introduction of the NSCPs resulted in a statistically significant decrease by 47% (IRR: 0.526, 95% CI: 0.384–0.720) of the total number of <italic>S. Enteritidis</italic> isolates.</p>
                <p>For <italic>S. Typhimurium</italic> we did not find a significant trend both before as well after the introduction of the NSCPs. Additionally, there was no evidence that the implementation of the intervention had an impact on the total number of <italic>S. Typhimurium</italic> isolates.</p>
                <p>Finally, regarding the “Control <italic>Salmonella</italic> serotypes”, before the introduction of the intervention there was no significant change in the reported monthly number of those isolates, while after the introduction of the intervention there was an increase by 0.45% on average per month (IRR: 1.004, 95%CI: 1.001–1.008).</p>
                <p><xref rid="antibiotics-10-00121-t002" ref-type="table">Table 2</xref> summarises the results of the interrupted time series analysis for the evaluation of the impact of the introduction of the NSCPs on the trend and the total number of <italic>S. Enteritidis</italic>, <italic>S. Typhimurium</italic> and “Control <italic>Salmonella</italic> serotypes” isolates.</p>
                <p><xref ref-type="fig" rid="antibiotics-10-00121-f002">Figure 2</xref> illustrates the distribution of <italic>Salmonella</italic> isolates due to: (<bold>a</bold>) <italic>S. Enteritidis</italic> (2006–2017), (<bold>b</bold>) <italic>S. Enteritidis</italic> (2006–2015), (<bold>c</bold>) <italic>S. Typhimurium</italic>, (<bold>d</bold>) “Control <italic>Salmonella</italic> serotypes” over time and the predicted number of isolates based to the model used.</p>
              </sec>
            </sec>
            <sec sec-type="discussion" id="sec3-antibiotics-10-00121">
              <title>3. Discussion</title>
              <p>This is the first study in Greece evaluating the impact of NSCPs in poultry breeding on human salmonellosis reported number of cases.</p>
              <p>Based on descriptive analysis, the number of human cases attributed to all serotypes, to <italic>S. Enteritidis</italic>, to <italic>S. Typhimurium</italic> and to “Control <italic>Salmonella</italic> serotypes” was decreased after the implementation of the NSCPs in 2008. However, after this initial decrease, the number of cases remained stable or increased for different time periods depending on the serotype.</p>
              <p>Overall, the results of the interrupted time series analysis support that the implementation of the NSCPs was followed by a reduction of the number of the total <italic>S. Enteritidis</italic> isolates in humans. This decrease resulted in the reduction of the total number of <italic>Salmonella</italic> isolates in humans. Similarly, a reduction in the human salmonellosis cases was also reported between 2005 and 2013 in several EU countries following the coordinated approach implemented at EU level for the control of salmonella in poultry [<xref rid="B14-antibiotics-10-00121" ref-type="bibr">14</xref>]. However, from 2014 to 2018, the trend in most of the member states became stable [<xref rid="B14-antibiotics-10-00121" ref-type="bibr">14</xref>].</p>
              <p>The aforementioned decrease was to be expected as according to EFSA, eggs and poultry meat are the main sources of transmission for <italic>S. Enteritidis</italic> and in Greece the NSCPs are only implemented in poultry populations [<xref rid="B14-antibiotics-10-00121" ref-type="bibr">14</xref>]. Therefore, the implementation of control measures against this serotype in poultry populations is important. The positive impact of the implementation of NSCPs on human salmonellosis has also been demonstrated in other member states and at European level [<xref rid="B14-antibiotics-10-00121" ref-type="bibr">14</xref>,<xref rid="B15-antibiotics-10-00121" ref-type="bibr">15</xref>,<xref rid="B16-antibiotics-10-00121" ref-type="bibr">16</xref>].</p>
              <p>On the other hand, NSCPs did not have an impact on the number of <italic>S. Typhimurium</italic> isolates, although Greece has achieved the EU targets in both layers and broilers and the prevalence of <italic>S. Typhimurium</italic> in both poultry species is very low [<xref rid="B17-antibiotics-10-00121" ref-type="bibr">17</xref>,<xref rid="B18-antibiotics-10-00121" ref-type="bibr">18</xref>]. Therefore, we can assume that NSCPs did not affect the trend and the number of <italic>S. Typhimurium</italic> isolates and that identified cases were probably attributed to other sources of infection, such as swine animals and their products [<xref rid="B14-antibiotics-10-00121" ref-type="bibr">14</xref>]. This is the reason why other countries have extended control programs to other susceptible animal species based on the results of a cost benefit analysis conducted at a national level [<xref rid="B16-antibiotics-10-00121" ref-type="bibr">16</xref>,<xref rid="B18-antibiotics-10-00121" ref-type="bibr">18</xref>,<xref rid="B19-antibiotics-10-00121" ref-type="bibr">19</xref>].</p>
              <p>According to our analysis, the number of reported monophasic <italic>S. Typhimurium</italic> 1,4 [<xref rid="B5-antibiotics-10-00121" ref-type="bibr">5</xref>],12: i: - isolates remained at about the same levels between 2012–2016 and increased in 2017. Although this serotype has been detected from fattening turkeys in Greece [<xref rid="B17-antibiotics-10-00121" ref-type="bibr">17</xref>,<xref rid="B18-antibiotics-10-00121" ref-type="bibr">18</xref>], turkeys cannot be considered an important source of human monophasic <italic>S. Typhimurium</italic> infection due to the small size of the turkeys’ population in the country [<xref rid="B17-antibiotics-10-00121" ref-type="bibr">17</xref>]. Taking also into account reports on the investigation of <italic>S. Typhimurium</italic> outbreaks, we can consider that pork meat and its products are important sources of monophasic <italic>S. Typhimurium</italic> infection in Greece [<xref rid="B13-antibiotics-10-00121" ref-type="bibr">13</xref>].</p>
              <p>Finally, the increasing trend of the number of “Control <italic>Salmonella</italic> serotypes” after the programmes’ implementation and the fact that programs did not have an impact on the number of “Control <italic>Salmonella</italic> serotypes” further supports our previous conclusions as we can assume that the reduction in the number of <italic>S. Enteritidis</italic> cases was not affected by a factor that had influenced <italic>Salmonella</italic> infection overall. On the other hand, the increased number of cases might suggest that other potential sources of infectivity exist and demonstrates the need for health education of the public regarding the prevention of salmonellosis infection, good hygiene and cooking practices [<xref rid="B20-antibiotics-10-00121" ref-type="bibr">20</xref>]. There is no doubt that educating the public will further enhance the positive impact of the NSCPs on the protection of public health from the targeted Salmonella serotypes. Finally, it is possible that the eradication of <italic>S</italic>.<italic>Enteritidis</italic> may leave a niche for other serotypes to fill [<xref rid="B21-antibiotics-10-00121" ref-type="bibr">21</xref>].</p>
              <p>A primary limitation of our study was that the absence of MLVA and WGS data in Greece did not allow us to differentiate outbreak-related cases from sporadic ones. We considered this limitation especially important during the European <italic>S.</italic> Enteritidis multi-country outbreak in 2016 and 2017, the largest ever documented <italic>S.</italic> Enteritidis outbreak in Europe, which was attributed to Polish-eggs originating from infected flocks [<xref rid="B13-antibiotics-10-00121" ref-type="bibr">13</xref>]. This is why sensitivity analysis was also performed for <italic>S.</italic> Enteritidis excluding 2016–2017 [<xref rid="B22-antibiotics-10-00121" ref-type="bibr">22</xref>].</p>
              <p>Another limitation regards the use of laboratory data on serotypes as proxy of the number of salmonellosis cases in humans, although we consider that this had a small impact on our results as the system was overall stable [<xref rid="B23-antibiotics-10-00121" ref-type="bibr">23</xref>].</p>
              <p>In conclusion, data support that the implementation of the NSCPs in poultry populations was followed by a decreased number of human salmonellosis cases. Programmes should continue, in order to keep meeting the EU targets, but for an effective public health program, the implementation of measures is needed in other animal species, as well as in all steps of food production (from farm to fork).</p>
            </sec>
            <sec id="sec4-antibiotics-10-00121">
              <title>4. Materials and Methods</title>
              <p>We extracted data from the National Reference Laboratory for <italic>Salmonella</italic> and <italic>Shigella</italic> (NRLSS) database in Greece for the period 2006–2017. The 2018–2019 data were excluded from the analysis as non-comparable with previous years due to changes in the operation of the reference laboratory. The NRLSS receives human <italic>Salmonella</italic> strains from the collaborating hospital laboratories across the country for serotyping and antimicrobial susceptibility testing. This system is universal but not mandatory and specimens sent at NRLSS are a proxy of the number of diagnosed salmonellosis cases at medical services of the country [<xref rid="B23-antibiotics-10-00121" ref-type="bibr">23</xref>].</p>
              <sec id="sec4dot1-antibiotics-10-00121">
                <title>4.1. Descriptive Analysis</title>
                <p>Outbreak-related cases were excluded from the analyses. Reported cases were classified as outbreak-related when the results of investigation indicated an epidemiological link to other reported salmonellosis cases with the same serotype. Time-series were plotted by month and summary statistics of the number of isolates per month and year were calculated to describe the distributions on possible outliers and missing data. Proportions of the different targeted <italic>Salmonella</italic> serotypes were also calculated and the distribution of the different serotypes over time (month and year) was plotted. Moreover, data were assessed for stationarity by checking for constant mean using a linear regression model and constant variance using a mean versus variance plot and autocorrelation (autocorrelation and partial autocorrelation). Normality was assessed using a Shapiro-Wilk normality test. To describe the trend and seasonality of the time series we used moving averages. Windows size 6 and 12 were used to highlight seasonality, and annual trend, respectively. Additional cyclical patterns were also assessed using spectral analysis.</p>
                <p>Analysis was conducted separately for (a) <italic>Salmonella</italic> spp. serotypes, (b) <italic>S. Enteritidis</italic>, (c) <italic>S. Typhimurium</italic>, (d) monophasic <italic>S. Typhimurium</italic>, (e) “control <italic>Salmonella</italic> serotypes”.</p>
                <p>“Control <italic>Salmonella</italic> serotypes” were those detected from human cases between 2004 and 2017, but were, either not detected or rarely detected (maximum of two times each) in poultry based on the data of the surveillance system for animal salmonellosis of the Greek Ministry of Rural Development and Food for 2011–2017 [<xref rid="B17-antibiotics-10-00121" ref-type="bibr">17</xref>].</p>
              </sec>
              <sec id="sec4dot2-antibiotics-10-00121">
                <title>4.2. Interrupted Time Series Analysis</title>
                <p>To assess the impact of the intervention (introduction of NSCPs) on the reported number of human salmonellosis cases, we used interrupted time series analysis and looked for changes after the intervention in important parameters of the model; intercept, slope and cyclical patterns. We defined intervention (<italic>S. Enteritidis</italic> and <italic>S. Typhimurium</italic>) and control series.</p>
                <p>Monophasic <italic>S. Typhimurium</italic> isolates were excluded as they have started to be recorded separately from <italic>S. Typhimurium</italic> only since 2012, after NSCPs had been launched.</p>
                <p>Control group (“Control <italic>Salmonella</italic> serotypes”) was used to test if the results for the targeted <italic>Salmonella</italic> serotypes had been affected by factors other than NSCPs’ implementation. This group was used as a “baseline” of the trend of the reported number of human salmonellosis cases in Greece.</p>
                <p>The study period for the interrupted time series analysis was 2006 to 2017. However, for <italic>S.</italic> Enteritidis, a sensitivity analysis was also performed for both periods 2006–2017 and 2006–2015. The reason was that in 2016 there was an excess in the number of <italic>S.</italic> Enteritidis cases in Greece probably attributed to the multi-country <italic>S. Enteritidis</italic> outbreak related to the consumption of infected Polish eggs [<xref rid="B14-antibiotics-10-00121" ref-type="bibr">14</xref>].</p>
                <p>Analysis was conducted separately for each series. We set the time of introduction of the intervention in January 2009, despite the fact that the implementation of the NSCPs in breeders, layers started in 2007, and 2008 respectively, as it takes some time for the NSCPs to produce results, namely reduction of the prevalence of the targeted <italic>Salmonella</italic> serotypes, in poultry species producing animal products for human consumption.</p>
                <p>Poisson and negative binomial regression models were used to study the impact of the intervention on the number and trend of the recorded isolates. The selection of the final model for the evaluation of the intervention’s impact was based on the residual analysis performed for these two models and was a negative binominal regression model which included trend and a sine wave with a 12-month period to adjust estimates for secular and cyclical trends, the intervention (a binominal variable), the interaction between trend and intervention and one lag to count for autocorrelation.</p>
                <p>IRR values and the respective CIs were calculated. In all cases, <italic>p</italic>-values &lt; 0.05 were considered statistically significant.</p>
                <p>Residuals of each model were plotted against the model and checked for stationarity, autocorrelation and normality. Additionally, residuals were tested with Portmanteau test to check if they were statistically significantly similar to white noise.</p>
                <p>Analysis was performed in Stata v16.1. [<xref rid="B24-antibiotics-10-00121" ref-type="bibr">24</xref>].</p>
              </sec>
            </sec>
          </body>
          <back>
            <ack>
              <title>Acknowledgments</title>
              <p>The authors appreciate the contribution of all personnel who collected data used in this study. Special thanks to Frantiska Hruba, EPIET Scientific Coordinator of European Centre for Disease Prevention and Control, Solna (ECDC) for her mentoring and support.</p>
            </ack>
            <fn-group>
              <fn>
                <p><bold>Publisher’s Note:</bold> MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
              </fn>
            </fn-group>
            <notes>
              <title>Author Contributions</title>
              <p>Conceptualization, M.T. and K.M.; data curation, M.T.; formal analysis, M.T.; investigation, M.T.; methodology, M.T., J.G.D. and K.M.; project administration, M.T.; supervision, K.M.; validation, K.M.; Visualization, M.T.; writing–original draft, M.T.; writing–review and editing, G.M., J.G.D., T.S., A.C. and K.M. All authors have read and agreed to the published version of the manuscript.</p>
            </notes>
            <notes>
              <title>Funding</title>
              <p>This research received no external funding.</p>
            </notes>
            <notes>
              <title>Institutional Review Board Statement</title>
              <p>“The study was conducted according to the guidelines of the Declaration of Helsinki. The data are publicly available at the official website of the National Reference Laboratory for <italic>Salmonella</italic>, <italic>Shigella</italic> and other enteropathogens at <uri xlink:href="http://www.mednet.gr/whonet/">http://www.mednet.gr/whonet/</uri>, but only until 2016. Further approval was not requested as only aggregated data on the number of <italic>Salmonella</italic> isolates were used.</p>
            </notes>
            <notes>
              <title>Informed Consent Statement</title>
              <p>Not applicable” as only aggregated data on <italic>Salmonella</italic> isolates were used. </p>
            </notes>
            <notes notes-type="data-availability">
              <title>Data Availability Statement</title>
              <p>The data presented in this study are available on request from the corresponding author. The data are publicly available at the official website of the National Reference Laboratory for <italic>Salmonella</italic>, <italic>Shigella</italic> and other enteropathogens at <uri xlink:href="http://www.mednet.gr/whonet/">http://www.mednet.gr/whonet/</uri>, but only until 2016.</p>
            </notes>
            <notes notes-type="COI-statement">
              <title>Conflicts of Interest</title>
              <p>The authors declare no conflict of interest.</p>
            </notes>
            <ref-list>
              <title>References</title>
              <ref id="B1-antibiotics-10-00121">
                <label>1.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Majowicz</surname>
                      <given-names>S.E.</given-names>
                    </name>
                    <name>
                      <surname>Musto</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Scallan</surname>
                      <given-names>E.</given-names>
                    </name>
                    <name>
                      <surname>Angulo</surname>
                      <given-names>F.J.</given-names>
                    </name>
                    <name>
                      <surname>Kirk</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>O’Brien</surname>
                      <given-names>S.J.</given-names>
                    </name>
                    <name>
                      <surname>Jones</surname>
                      <given-names>T.F.</given-names>
                    </name>
                    <name>
                      <surname>Fazil</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Hoekstra</surname>
                      <given-names>R.M.</given-names>
                    </name>
                  </person-group>
                  <article-title>The global burden of nontyphoidal Salmonella gastroenteritis</article-title>
                  <source>Clin. Infect. Dis.</source>
                  <year>2010</year>
                  <volume>50</volume>
                  <fpage>882</fpage>
                  <lpage>889</lpage>
                  <pub-id pub-id-type="doi">10.1086/650733</pub-id>
                  <?supplied-pmid 20158401?>
                  <pub-id pub-id-type="pmid">20158401</pub-id>
                </element-citation>
              </ref>
              <ref id="B2-antibiotics-10-00121">
                <label>2.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Eng</surname>
                      <given-names>S.K.</given-names>
                    </name>
                    <name>
                      <surname>Pusparajah</surname>
                      <given-names>P.</given-names>
                    </name>
                    <name>
                      <surname>Mutalib</surname>
                      <given-names>N.S.A.</given-names>
                    </name>
                    <name>
                      <surname>Ser</surname>
                      <given-names>H.L.</given-names>
                    </name>
                    <name>
                      <surname>Chan</surname>
                      <given-names>K.G.</given-names>
                    </name>
                    <name>
                      <surname>Lee</surname>
                      <given-names>L.H.</given-names>
                    </name>
                  </person-group>
                  <article-title>Salmonella: A review on pathogenesis, epidemiology and antibiotic resistance</article-title>
                  <source>Front. Life Sci.</source>
                  <year>2015</year>
                  <volume>8</volume>
                  <fpage>284</fpage>
                  <lpage>293</lpage>
                  <pub-id pub-id-type="doi">10.1080/21553769.2015.1051243</pub-id>
                </element-citation>
              </ref>
              <ref id="B3-antibiotics-10-00121">
                <label>3.</label>
                <element-citation publication-type="web">
                  <person-group person-group-type="author">
                    <collab>European Food Safety Authority (EFSA)</collab>
                  </person-group>
                  <article-title>Salmonella</article-title>
                  <comment>Available online: <ext-link ext-link-type="uri" xlink:href="https://www.efsa.europa.eu/en/topics/topic/salmonella">https://www.efsa.europa.eu/en/topics/topic/salmonella</ext-link></comment>
                  <date-in-citation content-type="access-date" iso-8601-date="2020-12-20">(accessed on 20 December 2020)</date-in-citation>
                </element-citation>
              </ref>
              <ref id="B4-antibiotics-10-00121">
                <label>4.</label>
                <element-citation publication-type="web">
                  <person-group person-group-type="author">
                    <collab>EUR-Lex: EU law</collab>
                  </person-group>
                  <article-title>Commission Regulation (EC) No 178/2002 of the European Parliament and of the Council of 28 January 2002 Laying Down the General Principles and Requirements of Food Law, Establishing the European Food Safety Authority and Laying Down Procedures in Matters of Food Safety. Official Journal L 1–24</article-title>
                  <comment>Available online: <ext-link ext-link-type="uri" xlink:href="https://eur-lex.europa.eu/legal-content/EN/ALL/?uri=celex%3A32002R0178">https://eur-lex.europa.eu/legal-content/EN/ALL/?uri=celex%3A32002R0178</ext-link></comment>
                  <date-in-citation content-type="access-date" iso-8601-date="2020-12-20">(accessed on 20 December 2020)</date-in-citation>
                </element-citation>
              </ref>
              <ref id="B5-antibiotics-10-00121">
                <label>5.</label>
                <element-citation publication-type="web">
                  <person-group person-group-type="author">
                    <collab>EUR-Lex: EU law</collab>
                  </person-group>
                  <article-title>Directive 2003/99/EC of the European Parliament and of the Council of 17 November 2003 on the Monitoring of Zoonoses and Zoonotic Agents, Amending Council Decision 90/424/EEC and Repealing Council Directive 92/117/EEC. Official Journal L 325, 12/12/2003 P. 0031–0040</article-title>
                  <comment>Available online: <ext-link ext-link-type="uri" xlink:href="https://eur-lex.europa.eu/legal-content/EN/TXT/HTML/?uri=CELEX:32003L0099&amp;from=EN">https://eur-lex.europa.eu/legal-content/EN/TXT/HTML/?uri=CELEX:32003L0099&amp;from=EN</ext-link></comment>
                  <date-in-citation content-type="access-date" iso-8601-date="2020-12-20">(accessed on 20 December 2020)</date-in-citation>
                </element-citation>
              </ref>
              <ref id="B6-antibiotics-10-00121">
                <label>6.</label>
                <element-citation publication-type="web">
                  <person-group person-group-type="author">
                    <collab>EUR-Lex: EU Law</collab>
                  </person-group>
                  <article-title>Commission Regulation (EC) No 2160/2003 of the European Parliament and of the Council of 17 November 2003 on the Control of Salmonella and Other Specified Food-Borne Zoonotic Agents</article-title>
                  <comment>Available online: <ext-link ext-link-type="uri" xlink:href="https://eur-lex.europa.eu/legal-content/EN/ALL/?uri=CELEX%3A32003R2160">https://eur-lex.europa.eu/legal-content/EN/ALL/?uri=CELEX%3A32003R2160</ext-link></comment>
                  <date-in-citation content-type="access-date" iso-8601-date="2020-12-20">(accessed on 20 December 2020)</date-in-citation>
                </element-citation>
              </ref>
              <ref id="B7-antibiotics-10-00121">
                <label>7.</label>
                <element-citation publication-type="web">
                  <person-group person-group-type="author">
                    <collab>EUR-Lex: EU Law</collab>
                  </person-group>
                  <article-title>Commission Regulation (EU) No 200/2010 of 10 March 2010 Implementing Regulation (EC) No 2160/2003 of the European Parliament and of the Council as Regards a Union Target for the Reduction of the Prevalence of Salmonella Serotypes in Adult Breeding Flocks of Gallus gallus. Official Journal of the European Union 1–9</article-title>
                  <comment>Available online: <ext-link ext-link-type="uri" xlink:href="https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX%3A32010R0200">https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX%3A32010R0200</ext-link></comment>
                  <date-in-citation content-type="access-date" iso-8601-date="2020-12-20">(accessed on 20 December 2020)</date-in-citation>
                </element-citation>
              </ref>
              <ref id="B8-antibiotics-10-00121">
                <label>8.</label>
                <element-citation publication-type="web">
                  <person-group person-group-type="author">
                    <collab>EUR-Lex: EU law</collab>
                  </person-group>
                  <article-title>Commission Regulation (EU) No 517/2011 of 25 May 2011 implementing Regulation (EC) No 2160/2003 of the European Parliament and of the Council as Regards a Union Target for the Reduction of the Prevalence of Certain Salmonella Serotypes in Laying Hens of Gallus Gallus and Amending Regulation (EC) No 2160/2003 and Commission Regulation (EU) No 200/2010. Official Journal of the European Union 45–51</article-title>
                  <comment>Available online: <ext-link ext-link-type="uri" xlink:href="https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:32011R0517">https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:32011R0517</ext-link></comment>
                  <date-in-citation content-type="access-date" iso-8601-date="2020-12-20">(accessed on 20 December 2020)</date-in-citation>
                </element-citation>
              </ref>
              <ref id="B9-antibiotics-10-00121">
                <label>9.</label>
                <element-citation publication-type="web">
                  <person-group person-group-type="author">
                    <collab>EUR-Lex: EU Law</collab>
                  </person-group>
                  <article-title>Commission Regulation (EU) No 200/2012 of 8 March 2012 Concerning a Union Target for the Reduction of Salmonella Enteritidis and Salmonella Typhimurium in Flocks of Broilers, as Provided for in Regulation (EC) No 2160/2003 of the European Parliament and of the Council. Official Journal of the European Union 31–36</article-title>
                  <comment>Available online: <ext-link ext-link-type="uri" xlink:href="https://eur-lex.europa.eu/legal-content/EN/ALL/?uri=CELEX%3A32012R0200">https://eur-lex.europa.eu/legal-content/EN/ALL/?uri=CELEX%3A32012R0200</ext-link></comment>
                  <date-in-citation content-type="access-date" iso-8601-date="2020-12-20">(accessed on 20 December 2020)</date-in-citation>
                </element-citation>
              </ref>
              <ref id="B10-antibiotics-10-00121">
                <label>10.</label>
                <element-citation publication-type="web">
                  <person-group person-group-type="author">
                    <collab>EUR-Lex: EU Law</collab>
                  </person-group>
                  <article-title>Commission Regulation (EU) No 1190/2012 of 12 December 2012 Concerning a Union Target for the Reduction of Salmonella Enteritidis and Salmonella Typhimurium in Flocks of Turkeys, as Provided for in Regulation (EC) No 2160/2003 of the European Parliament and of the Council</article-title>
                  <comment>Available online: <ext-link ext-link-type="uri" xlink:href="http://data.europa.eu/eli/reg/2012/1190/oj">http://data.europa.eu/eli/reg/2012/1190/oj</ext-link></comment>
                  <date-in-citation content-type="access-date" iso-8601-date="2020-12-20">(accessed on 20 December 2020)</date-in-citation>
                </element-citation>
              </ref>
              <ref id="B11-antibiotics-10-00121">
                <label>11.</label>
                <element-citation publication-type="web">
                  <person-group person-group-type="author">
                    <collab>EUR-Lex: EU Law</collab>
                  </person-group>
                  <article-title>Regulation (EC) No 2073/2005 of 15 November 2005 on Microbiological Criteria for Foodstuffs</article-title>
                  <comment>Available online: <ext-link ext-link-type="uri" xlink:href="https://eur-lex.europa.eu/legal-content/EN/ALL/?uri=CELEX%3A32005R2073">https://eur-lex.europa.eu/legal-content/EN/ALL/?uri=CELEX%3A32005R2073</ext-link></comment>
                  <date-in-citation content-type="access-date" iso-8601-date="2020-12-20">(accessed on 20 December 2020)</date-in-citation>
                </element-citation>
              </ref>
              <ref id="B12-antibiotics-10-00121">
                <label>12.</label>
                <element-citation publication-type="web">
                  <person-group person-group-type="author">
                    <collab>EUR-Lex: EU Law</collab>
                  </person-group>
                  <article-title>Commission Regulation (EC) No 1177/2006 of 1 August 2006 Implementing Regulation (EC) No 2160/2003 of the European Parliament and of the Council as Regards Requirements for the Use of Specific Control Methods in the Framework of the National Programmes for the Control of Salmonella in Poultry</article-title>
                  <comment>Available online: <ext-link ext-link-type="uri" xlink:href="http://data.europa.eu/eli/reg/2006/1177/oj">http://data.europa.eu/eli/reg/2006/1177/oj</ext-link></comment>
                  <date-in-citation content-type="access-date" iso-8601-date="2020-12-20">(accessed on 20 December 2020)</date-in-citation>
                </element-citation>
              </ref>
              <ref id="B13-antibiotics-10-00121">
                <label>13.</label>
                <element-citation publication-type="gov">
                  <article-title>Hellenic National Public Health Organisation (EODY): Epidemiological Data for Salmonellosis (Non-Typhoid/Paratyphoid) in Greece, 2004–2019</article-title>
                  <comment>Available online: <ext-link ext-link-type="uri" xlink:href="https://eody.gov.gr/en/epidemiological-statistical-data/annual-epidemiological-data/#heading-13">https://eody.gov.gr/en/epidemiological-statistical-data/annual-epidemiological-data/#heading-13</ext-link></comment>
                  <date-in-citation content-type="access-date" iso-8601-date="2020-12-20">(accessed on 20 December 2020)</date-in-citation>
                </element-citation>
              </ref>
              <ref id="B14-antibiotics-10-00121">
                <label>14.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <collab>EFSA and ECDC (European Food Safety Authority and European Centre for Disease Prevention and Control)</collab>
                  </person-group>
                  <article-title>The European Union One Health 2018 Zoonoses Report</article-title>
                  <source>EFSA J.</source>
                  <year>2019</year>
                  <volume>17</volume>
                  <fpage>e05926</fpage>
                  <pub-id pub-id-type="doi">10.2903/j.efsa.2019.5926</pub-id>
                  <pub-id pub-id-type="pmid">32626211</pub-id>
                </element-citation>
              </ref>
              <ref id="B15-antibiotics-10-00121">
                <label>15.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Poirier</surname>
                      <given-names>E.</given-names>
                    </name>
                    <name>
                      <surname>Watier</surname>
                      <given-names>L.</given-names>
                    </name>
                    <name>
                      <surname>Espie</surname>
                      <given-names>E.</given-names>
                    </name>
                    <name>
                      <surname>Weill</surname>
                      <given-names>F.X.</given-names>
                    </name>
                    <name>
                      <surname>De Valk</surname>
                      <given-names>H.</given-names>
                    </name>
                    <name>
                      <surname>Desenclos</surname>
                      <given-names>J.C.</given-names>
                    </name>
                  </person-group>
                  <article-title>Evaluation of the impact on human salmonellosis of control measures targeted to Salmonella Enteritidis and Typhimurium in poultry breeding using time-series analysis and intervention models in France</article-title>
                  <source>Epidemiol. Infect.</source>
                  <year>2008</year>
                  <volume>136</volume>
                  <fpage>1217</fpage>
                  <lpage>1224</lpage>
                  <pub-id pub-id-type="doi">10.1017/S0950268807009788</pub-id>
                  <?supplied-pmid 18047748?>
                  <pub-id pub-id-type="pmid">18047748</pub-id>
                </element-citation>
              </ref>
              <ref id="B16-antibiotics-10-00121">
                <label>16.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Wegener</surname>
                      <given-names>H.C.</given-names>
                    </name>
                    <name>
                      <surname>Hald</surname>
                      <given-names>T.</given-names>
                    </name>
                    <name>
                      <surname>Lo Fo Wong</surname>
                      <given-names>D.</given-names>
                    </name>
                    <name>
                      <surname>Madsen</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Korsgaard</surname>
                      <given-names>H.</given-names>
                    </name>
                    <name>
                      <surname>Bager</surname>
                      <given-names>F.</given-names>
                    </name>
                    <name>
                      <surname>Gerner-Smidt</surname>
                      <given-names>P.</given-names>
                    </name>
                    <name>
                      <surname>Mølbak</surname>
                      <given-names>K.</given-names>
                    </name>
                  </person-group>
                  <article-title>Salmonella control programs in Denmark</article-title>
                  <source>Emerg. Infect. Dis.</source>
                  <year>2003</year>
                  <volume>9</volume>
                  <fpage>774</fpage>
                  <lpage>780</lpage>
                  <pub-id pub-id-type="doi">10.3201/eid0907.030024</pub-id>
                  <?supplied-pmid 12890316?>
                  <pub-id pub-id-type="pmid">12890316</pub-id>
                </element-citation>
              </ref>
              <ref id="B17-antibiotics-10-00121">
                <label>17.</label>
                <element-citation publication-type="web">
                  <person-group person-group-type="author">
                    <collab>Hellenic Ministry of Rural Development and Food</collab>
                  </person-group>
                  <article-title>Reports of the Multiannual Control Programmes</article-title>
                  <comment>Available online: <ext-link ext-link-type="uri" xlink:href="http://www.minagric.gr/index.php/el/the-ministry-2/poese">http://www.minagric.gr/index.php/el/the-ministry-2/poese</ext-link></comment>
                  <date-in-citation content-type="access-date" iso-8601-date="2020-12-20">(accessed on 20 December 2020)</date-in-citation>
                </element-citation>
              </ref>
              <ref id="B18-antibiotics-10-00121">
                <label>18.</label>
                <element-citation publication-type="web">
                  <person-group person-group-type="author">
                    <collab>EFSA (European Food Safety Authoritiy)</collab>
                  </person-group>
                  <article-title>National Zoonoses Country Reports</article-title>
                  <comment>Available online: <ext-link ext-link-type="uri" xlink:href="http://www.efsa.europa.eu/en/biological-hazards-data/reports">http://www.efsa.europa.eu/en/biological-hazards-data/reports</ext-link></comment>
                  <date-in-citation content-type="access-date" iso-8601-date="2020-12-20">(accessed on 20 December 2020)</date-in-citation>
                </element-citation>
              </ref>
              <ref id="B19-antibiotics-10-00121">
                <label>19.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Maijala</surname>
                      <given-names>R.</given-names>
                    </name>
                    <name>
                      <surname>Ranta</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Seuna</surname>
                      <given-names>E.</given-names>
                    </name>
                    <name>
                      <surname>Peltola</surname>
                      <given-names>J.</given-names>
                    </name>
                  </person-group>
                  <article-title>The efficiency of the Finnish Salmonella Control Programme</article-title>
                  <source>Food Control</source>
                  <year>2005</year>
                  <volume>16</volume>
                  <fpage>669</fpage>
                  <lpage>675</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.foodcont.2004.06.003</pub-id>
                </element-citation>
              </ref>
              <ref id="B20-antibiotics-10-00121">
                <label>20.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>van Velsen</surname>
                      <given-names>L.</given-names>
                    </name>
                    <name>
                      <surname>Beaujean</surname>
                      <given-names>D.J.</given-names>
                    </name>
                    <name>
                      <surname>van Gemert-Pijnen</surname>
                      <given-names>J.E.</given-names>
                    </name>
                    <name>
                      <surname>van Steenbergen</surname>
                      <given-names>J.E.</given-names>
                    </name>
                    <name>
                      <surname>Timen</surname>
                      <given-names>A.</given-names>
                    </name>
                  </person-group>
                  <article-title>Public knowledge and preventive behavior during a large-scale Salmonella outbreak: Results from an online survey in the Netherlands</article-title>
                  <source>BMC Public Health</source>
                  <year>2014</year>
                  <volume>14</volume>
                  <elocation-id>100</elocation-id>
                  <pub-id pub-id-type="doi">10.1186/1471-2458-14-100</pub-id>
                  <?supplied-pmid 24479614?>
                  <pub-id pub-id-type="pmid">24479614</pub-id>
                </element-citation>
              </ref>
              <ref id="B21-antibiotics-10-00121">
                <label>21.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Cogan</surname>
                      <given-names>T.A.</given-names>
                    </name>
                    <name>
                      <surname>Humphrey</surname>
                      <given-names>T.J.</given-names>
                    </name>
                  </person-group>
                  <article-title>The rise and fall of Salmonella enteritidis in the UK</article-title>
                  <source>J. Appl. Microbiol.</source>
                  <year>2003</year>
                  <volume>94</volume>
                  <fpage>114S</fpage>
                  <lpage>119S</lpage>
                  <pub-id pub-id-type="doi">10.1046/j.1365-2672.94.s1.13.x</pub-id>
                  <?supplied-pmid 12675943?>
                  <pub-id pub-id-type="pmid">12675943</pub-id>
                </element-citation>
              </ref>
              <ref id="B22-antibiotics-10-00121">
                <label>22.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Pijnacker</surname>
                      <given-names>R.</given-names>
                    </name>
                    <name>
                      <surname>Dallman</surname>
                      <given-names>T.J.</given-names>
                    </name>
                    <name>
                      <surname>Tijsma</surname>
                      <given-names>A.S.L.</given-names>
                    </name>
                    <name>
                      <surname>Hawkins</surname>
                      <given-names>G.</given-names>
                    </name>
                    <name>
                      <surname>Larkin</surname>
                      <given-names>L.</given-names>
                    </name>
                    <name>
                      <surname>Kotila</surname>
                      <given-names>S.M.</given-names>
                    </name>
                    <name>
                      <surname>Amore</surname>
                      <given-names>G.</given-names>
                    </name>
                    <name>
                      <surname>Amato</surname>
                      <given-names>E.</given-names>
                    </name>
                    <name>
                      <surname>Suzuki</surname>
                      <given-names>P.M.</given-names>
                    </name>
                    <name>
                      <surname>Denayer</surname>
                      <given-names>S.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>International Outbreak Investigation Team. An international outbreak of Salmonella enterica serotype Enteritidis linked to eggs from Poland: A microbiological and epidemiological study</article-title>
                  <source>Lancet Infect Dis.</source>
                  <year>2019</year>
                  <volume>19</volume>
                  <fpage>778</fpage>
                  <lpage>786</lpage>
                  <pub-id pub-id-type="doi">10.1016/S1473-3099(19)30047-7</pub-id>
                  <pub-id pub-id-type="pmid">31133519</pub-id>
                </element-citation>
              </ref>
              <ref id="B23-antibiotics-10-00121">
                <label>23.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Mellou</surname>
                      <given-names>K.</given-names>
                    </name>
                    <name>
                      <surname>Sideroglou</surname>
                      <given-names>T.</given-names>
                    </name>
                    <name>
                      <surname>Kallimani</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Potamiti-Komi</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Pervanidou</surname>
                      <given-names>D.</given-names>
                    </name>
                    <name>
                      <surname>Lillakou</surname>
                      <given-names>E.</given-names>
                    </name>
                    <name>
                      <surname>Georgakopoulou</surname>
                      <given-names>T.</given-names>
                    </name>
                    <name>
                      <surname>Mandilara</surname>
                      <given-names>G.</given-names>
                    </name>
                    <name>
                      <surname>Lambiri</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Vatopoulos</surname>
                      <given-names>A.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Evaluation of underreporting of salmonellosis and shigellosis hospitalised cases in Greece, 2011: Results of a capture-recapture study and a hospital registry review</article-title>
                  <source>BMC Public Health</source>
                  <year>2013</year>
                  <volume>13</volume>
                  <elocation-id>875</elocation-id>
                  <pub-id pub-id-type="doi">10.1186/1471-2458-13-875</pub-id>
                  <?supplied-pmid 24060206?>
                  <pub-id pub-id-type="pmid">24060206</pub-id>
                </element-citation>
              </ref>
              <ref id="B24-antibiotics-10-00121">
                <label>24.</label>
                <element-citation publication-type="book">
                  <person-group person-group-type="author">
                    <collab>StataCorp</collab>
                  </person-group>
                  <source>Stata Statistical Software: Release 16</source>
                  <publisher-name>StataCorp LLC</publisher-name>
                  <publisher-loc>College Station, TX, USA</publisher-loc>
                  <year>2019</year>
                </element-citation>
              </ref>
            </ref-list>
          </back>
          <floats-group>
            <fig id="antibiotics-10-00121-f001" orientation="portrait" position="float">
              <label>Figure 1</label>
              <caption>
                <p>Monthly number of <italic>Salmonella</italic> spp., <italic>S. Enteritidis</italic>, <italic>S. Typhimurium</italic>, monophasic <italic>S. Typhimurium</italic> and “Control <italic>Salmonella</italic> serotypes” of human isolates and 12-month moving average.(<bold>a</bold>) Monthly cases attributed to <italic>Salmonella</italic> spp. and 12-month moving average, Greece, 2006–2017; (<bold>b</bold>) Monthly cases attributed to <italic>S. Enteritidis</italic> and 12-month moving average, Greece, 2006–2017; (<bold>c</bold>) Monthly cases attributed to <italic>S. Typhimurium</italic> and 12-month moving average, Greece, 2006–2017; (<bold>d</bold>) Monthly cases attributed to monophasic <italic>S. Typhimurium</italic> and 12-month moving average, Greece, 2012–2017 (Data on monophasic <italic>S. Typhimurium</italic> were only available since 2012 and the introduction of the NSCPs was much earlier in 2009, therefore there is no arrow in panel (<bold>d</bold>); (<bold>e</bold>) Monthly cases attributed to “Control <italic>Salmonella</italic> serotypes” (serotypes detected from human cases between 2004 and 2017 but were either not detected or rarely detected, maximum of two times each, in poultry) and 12-month moving average, Greece, 2006–2017.</p>
              </caption>
              <graphic xlink:href="antibiotics-10-00121-g001"/>
            </fig>
            <fig id="antibiotics-10-00121-f002" orientation="portrait" position="float">
              <label>Figure 2</label>
              <caption>
                <p>Number of observed and predicted human <italic>Salmonella</italic> isolates, Greece, 2006–2017; (<bold>a</bold>) Number of observed and predicted human <italic>S. Enteritidis</italic> isolates according to the model used, Greece, 2006–2017; (<bold>b</bold>) Number of observed and predicted human <italic>S. Enteritidis</italic> isolates according to the model used, Greece, 2006–2015 (For <italic>S. Enteritidis</italic>, a sensitivity analysis was also performed for both periods 2006–2017 and 2006–2015. The reason was that in 2016 there was an excess in the number of <italic>S. Enteritidis</italic> cases in Greece probably attributed to the multi-country <italic>S. Enteritidis</italic> outbreak related to the consumption of infected Polish eggs); (<bold>c</bold>) Number of observed and predicted human <italic>S. Typhi-murium</italic> isolates according to the model used, Greece, 2006–2017; (<bold>d</bold>) Number of observed and predicted human isolates attributed to “Control <italic>Salmonella</italic> serotypes” (serotypes detected from human cases between 2004 and 2017, but were either not detected or rarely detected, the maximum of two times each, in poultry) according to the model used, Greece, 2006–2017.</p>
              </caption>
              <graphic xlink:href="antibiotics-10-00121-g002"/>
            </fig>
            <table-wrap id="antibiotics-10-00121-t001" orientation="portrait" position="float">
              <object-id pub-id-type="pii">antibiotics-10-00121-t001_Table 1</object-id>
              <label>Table 1</label>
              <caption>
                <p>Trends of the number of <italic>Salmonella</italic> spp., <italic>S</italic>. <italic>Enteritidis</italic>, <italic>S. Typhimurium</italic>, monophasic <italic>S. Typhimurium</italic> and “Control <italic>Salmonella</italic> serotypes” of human isolates, Greece, 2006–2017.</p>
              </caption>
              <table frame="hsides" rules="groups">
                <thead>
                  <tr>
                    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Salmonella Serotype</th>
                    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Trend</th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td align="center" valign="middle" rowspan="1" colspan="1"><italic>Salmonella</italic> spp.</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">Statistically significantly decreasing<break/>(IRR: 0.996, <italic>p</italic>-value &lt; 0.001, 95% CI: 0.995–0.998)</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
                      <italic>S. Enteritidis</italic>
                    </td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">Statistically significantly decreasing <break/>(IRR: 0.992, <italic>p</italic>-value &lt; 0.001, 95% CI: 0.990–0.994)</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
                      <italic>S. Typhimurium</italic>
                    </td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">No evidence for significant trend<break/>(IRR: 0.998, <italic>p</italic>-value = 0.287, 95% CI: 0.996–1.001)</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" rowspan="1" colspan="1">Monophasic <italic>S. Typhimurium</italic></td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">No evidence for significant trend<break/>(IRR: 0.992, <italic>p</italic>-value = 0.134, 95% CI: 0.983–1.002)</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"> “Control <italic>Salmonella</italic> serotypes” <sup>1</sup></td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No evidence for significant trend<break/>(IRR: 0.999, <italic>p</italic>-value = 0.834, 95% CI: 0.997–1.002)</td>
                  </tr>
                </tbody>
              </table>
              <table-wrap-foot>
                <fn>
                  <p><sup>1</sup> serotypes detected from human cases between 2004 and 2017 but were either not detected or rarely detected, maximum of two times each, in poultry.</p>
                </fn>
              </table-wrap-foot>
            </table-wrap>
            <table-wrap id="antibiotics-10-00121-t002" orientation="portrait" position="float">
              <object-id pub-id-type="pii">antibiotics-10-00121-t002_Table 2</object-id>
              <label>Table 2</label>
              <caption>
                <p>Results of the evaluation of the impact of the introduction of the National Salmonella Control Programmes (NSCPs) on the trend and total number of <italic>S</italic>. <italic>Enteritidis</italic>, <italic>S</italic>. <italic>Typhimurium</italic> and “Control <italic>Salmonella</italic> serotypes” of human isolates.</p>
              </caption>
              <table frame="hsides" rules="groups">
                <thead>
                  <tr>
                    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1"><italic>Salmonella</italic> Serotypes</th>
                    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Trend of Salmonellosis before the NSCPs’ Implementation</th>
                    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Trend of Salmonellosis after the NSCPs’ Implementation</th>
                    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Impact of the NSCPs on the Total Number of <italic>Salmonella</italic> Isolates</th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td align="center" valign="middle" rowspan="1" colspan="1"><italic>S. Enteritidis</italic> (2006–2017) </td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">No evidence for significant trend (IRR = 1.001, <italic>p</italic>-value = 0.886, 95% CI = 0.983–1.019)</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">No evidence for significant trend (IRR = 1.000, <italic>p</italic>-value = 0.804, 95% CI = 0.997–1.003)</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">49% decrease (IRR: 0.511, <italic>p</italic>-value &lt; 0.001, 95% CI: 0.353–0.739)</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" rowspan="1" colspan="1"><italic>S. Enteritidis</italic> (2006–2015) <sup>2</sup></td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">No evidence for significant trend (IRR = 1.002, <italic>p</italic>-value = 0.781, 95% CI = 0.987–1.017)</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">Statistically significant decreasing trend (IRR: 0.990, <italic>p</italic>-value &lt; 0.001, 95% CI: 0.986–0.995)</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">47% decrease (IRR: 0.526, <italic>p</italic>-value &lt; 0.001, 95% CI: 0.384–0.720)</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" rowspan="1" colspan="1"><italic>S</italic>. <italic>Typhimurium</italic></td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">No evidence for significant trend (IRR = 0.981, <italic>p</italic>-value = 0.077, 95% CI = 0.962–1.001)</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">No evidence for significant trend (IRR = 0.999, <italic>p</italic>-value = 0.994, 95% CI = 0.996–1.003)</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">No evidence for statistically significant impact (IRR = 0.941, <italic>p</italic>-value = 0.741, 95% CI = 0.660–1.343)</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">“Control <italic>Salmonella</italic> serotypes” <sup>3</sup>
</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No evidence for significant trend (IRR = 0.990, <italic>p</italic>-value = 0.226, 95% CI = 0.974–1.006</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Statistically significant increasing trend (IRR:1.004, <italic>p</italic>-value = 0.011, 95% CI: 1.001–1.008)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No evidence for statistically significant impact (IRR: 0.0001, <italic>p</italic>-value = 0.069, 95% CI: 0.000–1.987)</td>
                  </tr>
                </tbody>
              </table>
              <table-wrap-foot>
                <fn>
                  <p><sup>2</sup> For <italic>S</italic>. <italic>Enteritidis</italic>, a sensitivity analysis was also performed for both periods 2006–2017 and 2006–2015. The reason was that in 2016 there was an excess in the number of <italic>S</italic>. <italic>Enteritidis</italic> cases in Greece probably attributed to the multi-country <italic>S</italic>. <italic>Enteritidis</italic> outbreak related to the consumption of infected Polish eggs. <sup>3</sup> serotypes detected from human cases between 2004 and 2017 but were either not detected or rarely detected, maximum of two times each, in poultry.</p>
                </fn>
              </table-wrap-foot>
            </table-wrap>
          </floats-group>
        </article>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
